CLINICAL_TRIALS
trial_result
· 2017-07-18
Clinical Trial Update: Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares [Phase 3]
Summary
A Phase 3 trial evaluating long-term rilonacept to prevent gout flares was terminated, with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Regeneron Pharmaceuticals | Conditions: Gout | Phase 3 | Status: TERMINATED | Results posted: 2017-07-18